FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3754662012 | Transthyretin synthesis inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3754663019 | Substance with transthyretin synthesis inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Transthyretin synthesis inhibitor | Is a | Substance categorized by disposition | true | Inferred relationship | Some | ||
| Transthyretin synthesis inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Transthyretin synthesis inhibitor (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Inotersen sodium (substance) | Is a | True | Transthyretin synthesis inhibitor | Inferred relationship | Some | |
| Inotersen (substance) | Is a | True | Transthyretin synthesis inhibitor | Inferred relationship | Some | |
| Product containing transthyretin synthesis inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Transthyretin synthesis inhibitor | Inferred relationship | Some | 1 |
This concept is not in any reference sets